1-3 of 3
Lori Westendorf
Close
Sort by
Journal Articles

SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma

Tim S. Lewis, PhD, Devra Olson, B.S., Kristine Gordon, B.S., Sharsti Sandall, PhD, Marsha Quick, B.S., Margo Finn, B.S., Lori Westendorf, B.S., Germein Linares, B.S., Chris Leiske, B.S., Albina Nesterova, B.S., Lanshan Huang, B.S., Maitrayee Goswami, B.S., Sa Wang, MD, Che-Leung Law, PhD
Journal: Blood
Blood (2016) 128 (22): 4470.
https://doi.org/10.1182/blood.V128.22.4470.4470
Published: 2016
Journal Articles

SGN-CD123A, a Pyrrolobenzodiazepine Dimer Linked Anti-CD123 Antibody Drug Conjugate, Demonstrates Effective Anti-Leukemic Activity in Multiple Preclinical Models of AML

May S.K. Sutherland, PhD, Changpu Yu, Roland B. Walter, MD PhD, Lori Westendorf, John Valliere-Douglass, PhD, Lucy Pan, PhD, Django Sussman, PhD, Martha Anderson, Weiping Zeng, Ivan Stone, Kerry Klussman, Michelle Ulrich, Mechthild Jonas, PhD, Peter Senter, PhD, Jonathan G. Drachman, MD, Dennis Benjamin, PhD
Journal: Blood
Blood (2015) 126 (23): 330.
https://doi.org/10.1182/blood.V126.23.330.330
Published: 2015
Journal Articles

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S. Kung Sutherland, Roland B. Walter, Scott C. Jeffrey, Patrick J. Burke, Changpu Yu, Heather Kostner, Ivan Stone, Maureen C. Ryan, Django Sussman, Robert P. Lyon, Weiping Zeng, Kimberly H. Harrington, Kerry Klussman, Lori Westendorf, David Meyer, Irwin D. Bernstein, Peter D. Senter, Dennis R. Benjamin, Jonathan G. Drachman, Julie A. McEarchern
Journal: Blood
Blood (2013) 122 (8): 1455–1463.
https://doi.org/10.1182/blood-2013-03-491506
Published: 2013
Includes: Supplemental data